2 Dividend Stocks That Are No-Brainer Buys in August
They have businesses built to handle the toughest environments.
Overview
Broader equities have been volatile this year, and there is no telling what may come next. Perhaps geopolitical tensions, inflation, and other macroeconomic factors will intensify, leading to a bear market. We can't predict that for sure, but as the famous motto goes, it's always good to be prepared. To that end, it makes sense to invest in rock-solid dividend stocks, which can generally navigate challenging times better than most other corporations. With that said, let's consider two dividend stocks that look like great buys right now: AbbVie (NYSE: ABBV) and Merck (NYSE: MRK).
Image source: The Motley Fool.
Let's consider two key reasons why AbbVie may be a great stock to own in the current landscape. First, as a pharmaceutical leader, it offers essential products. No one wants to cut back on prescription drugs, and patients who foot only part of the bill (while insurance pays for the rest) aren't going to be willing to do so even in a downturn. Second, AbbVie has shown that it can overcome one of the most important risks drugmakers face: The dreaded patent cliff.
Details
Source
Originally published at www.fool.com.
Related Articles
- Bloom Energy Says It Has Visibility on 25 Gigawatts of Deployments. Here's What That Would Be Worth.
- Stock futures are little changed after Wall Street starts the week with losses, hurt by higher oil prices and rising yields: Live updates
- South Korea must brace for ‘worst-case scenario,’ President Lee says, as Trump cuts military drills